Integra LifeSciences Holdings Corporation (IART)
USD 18.75
(-4.19%)
USD 18.75
(-4.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 888.39 Million USD | -8.44% |
| 2022 | 970.31 Million USD | 2.72% |
| 2021 | 944.64 Million USD | 11.0% |
| 2020 | 851.03 Million USD | -10.69% |
| 2019 | 952.87 Million USD | 5.76% |
| 2018 | 900.94 Million USD | 19.69% |
| 2017 | 752.72 Million USD | 17.07% |
| 2016 | 642.98 Million USD | 15.61% |
| 2015 | 556.19 Million USD | -3.36% |
| 2014 | 575.5 Million USD | 14.61% |
| 2013 | 502.12 Million USD | -2.77% |
| 2012 | 516.44 Million USD | 7.38% |
| 2011 | 480.92 Million USD | 3.68% |
| 2010 | 463.88 Million USD | 6.01% |
| 2009 | 437.56 Million USD | 8.91% |
| 2008 | 401.77 Million USD | 19.65% |
| 2007 | 335.78 Million USD | 33.79% |
| 2006 | 250.98 Million USD | 45.58% |
| 2005 | 172.39 Million USD | 20.96% |
| 2004 | 142.52 Million USD | 23.93% |
| 2003 | 115 Million USD | 72.02% |
| 2002 | 66.85 Million USD | 16.41% |
| 2001 | 57.42 Million USD | 50.45% |
| 2000 | 38.17 Million USD | 84.4% |
| 1999 | 20.7 Million USD | 81.58% |
| 1998 | 11.4 Million USD | 20.0% |
| 1997 | 9.5 Million USD | 13.1% |
| 1996 | 8.4 Million USD | 25.37% |
| 1995 | 6.7 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 203.85 Million USD | -13.87% |
| 2024 Q1 | 206.83 Million USD | -11.6% |
| 2024 Q2 | 232.47 Million USD | 12.39% |
| 2023 Q4 | 233.97 Million USD | 7.16% |
| 2023 Q1 | 232.87 Million USD | -6.88% |
| 2023 FY | 888.39 Million USD | -8.44% |
| 2023 Q3 | 218.34 Million USD | 5.47% |
| 2023 Q2 | 207.02 Million USD | -11.1% |
| 2022 FY | 970.31 Million USD | 2.72% |
| 2022 Q3 | 236.74 Million USD | -5.08% |
| 2022 Q4 | 250.08 Million USD | 5.63% |
| 2022 Q2 | 249.41 Million USD | 6.55% |
| 2022 Q1 | 234.06 Million USD | -6.1% |
| 2021 Q1 | 214.24 Million USD | -11.31% |
| 2021 Q3 | 242.39 Million USD | 1.54% |
| 2021 Q4 | 249.27 Million USD | 2.84% |
| 2021 FY | 944.64 Million USD | 11.0% |
| 2021 Q2 | 238.72 Million USD | 11.42% |
| 2020 Q1 | 220.84 Million USD | -10.1% |
| 2020 Q3 | 235.42 Million USD | 53.68% |
| 2020 Q4 | 241.57 Million USD | 2.62% |
| 2020 FY | 851.03 Million USD | -10.69% |
| 2020 Q2 | 153.18 Million USD | -30.64% |
| 2019 Q2 | 239.97 Million USD | 3.98% |
| 2019 Q3 | 236.45 Million USD | -1.46% |
| 2019 Q4 | 245.66 Million USD | 3.89% |
| 2019 FY | 952.87 Million USD | 5.76% |
| 2019 Q1 | 230.77 Million USD | -2.56% |
| 2018 Q4 | 236.85 Million USD | 6.4% |
| 2018 Q2 | 228.62 Million USD | 7.41% |
| 2018 Q1 | 212.86 Million USD | -3.43% |
| 2018 FY | 900.94 Million USD | 19.69% |
| 2018 Q3 | 222.6 Million USD | -2.63% |
| 2017 Q2 | 183.16 Million USD | 6.46% |
| 2017 Q3 | 177.07 Million USD | -3.32% |
| 2017 Q4 | 220.43 Million USD | 24.48% |
| 2017 FY | 752.72 Million USD | 17.07% |
| 2017 Q1 | 172.05 Million USD | 1.06% |
| 2016 Q3 | 161 Million USD | 0.79% |
| 2016 Q4 | 170.24 Million USD | 5.74% |
| 2016 FY | 642.98 Million USD | 15.61% |
| 2016 Q2 | 159.74 Million USD | 5.1% |
| 2016 Q1 | 151.99 Million USD | 0.55% |
| 2015 Q4 | 151.15 Million USD | 7.74% |
| 2015 Q1 | 146.94 Million USD | -5.02% |
| 2015 Q2 | 157.53 Million USD | 7.21% |
| 2015 Q3 | 140.29 Million USD | -10.94% |
| 2015 FY | 556.19 Million USD | -3.36% |
| 2014 Q4 | 154.7 Million USD | 7.63% |
| 2014 Q3 | 143.74 Million USD | -0.44% |
| 2014 FY | 575.5 Million USD | 14.61% |
| 2014 Q1 | 132.67 Million USD | -1.08% |
| 2014 Q2 | 144.37 Million USD | 8.82% |
| 2013 Q2 | 122.47 Million USD | 5.24% |
| 2013 Q4 | 134.12 Million USD | 3.85% |
| 2013 FY | 502.12 Million USD | -2.77% |
| 2013 Q1 | 116.38 Million USD | -12.16% |
| 2013 Q3 | 129.14 Million USD | 5.44% |
| 2012 Q2 | 131.89 Million USD | 8.55% |
| 2012 Q3 | 130.53 Million USD | -1.03% |
| 2012 Q4 | 132.5 Million USD | 1.51% |
| 2012 FY | 516.44 Million USD | 7.38% |
| 2012 Q1 | 121.51 Million USD | 0.6% |
| 2011 Q3 | 123.53 Million USD | 2.53% |
| 2011 Q1 | 116.12 Million USD | -5.46% |
| 2011 Q2 | 120.49 Million USD | 3.76% |
| 2011 Q4 | 120.78 Million USD | -2.23% |
| 2011 FY | 480.92 Million USD | 3.68% |
| 2010 Q3 | 117.44 Million USD | 2.91% |
| 2010 Q1 | 109.47 Million USD | -8.45% |
| 2010 FY | 463.88 Million USD | 6.01% |
| 2010 Q4 | 122.82 Million USD | 4.58% |
| 2010 Q2 | 114.13 Million USD | 4.25% |
| 2009 Q4 | 119.58 Million USD | 9.44% |
| 2009 Q1 | 102.8 Million USD | -3.23% |
| 2009 Q2 | 105.92 Million USD | 3.03% |
| 2009 FY | 437.56 Million USD | 8.91% |
| 2009 Q3 | 109.26 Million USD | 3.16% |
| 2008 Q4 | 106.23 Million USD | 3.43% |
| 2008 FY | 401.77 Million USD | 19.65% |
| 2008 Q3 | 102.71 Million USD | 3.71% |
| 2008 Q2 | 99.03 Million USD | 5.59% |
| 2008 Q1 | 93.79 Million USD | -1.49% |
| 2007 FY | 335.78 Million USD | 33.79% |
| 2007 Q4 | 95.21 Million USD | 13.15% |
| 2007 Q3 | 84.15 Million USD | 2.68% |
| 2007 Q1 | 74.45 Million USD | 0.68% |
| 2007 Q2 | 81.95 Million USD | 10.08% |
| 2006 Q2 | 58.74 Million USD | 19.41% |
| 2006 Q3 | 69.08 Million USD | 17.6% |
| 2006 Q4 | 73.94 Million USD | 7.04% |
| 2006 FY | 250.98 Million USD | 45.58% |
| 2006 Q1 | 49.19 Million USD | 9.98% |
| 2005 FY | 172.39 Million USD | 20.96% |
| 2005 Q4 | 44.73 Million USD | 3.26% |
| 2005 Q1 | 41.7 Million USD | 8.07% |
| 2005 Q2 | 42.63 Million USD | 2.24% |
| 2005 Q3 | 43.32 Million USD | 1.6% |
| 2004 Q1 | 32.44 Million USD | -14.83% |
| 2004 Q4 | 38.59 Million USD | 5.1% |
| 2004 Q3 | 36.71 Million USD | 5.58% |
| 2004 Q2 | 34.77 Million USD | 7.19% |
| 2004 FY | 142.52 Million USD | 23.93% |
| 2003 Q1 | 23.07 Million USD | 45.17% |
| 2003 FY | 115 Million USD | 72.02% |
| 2003 Q4 | 38.09 Million USD | 35.13% |
| 2003 Q3 | 28.18 Million USD | 9.91% |
| 2003 Q2 | 25.64 Million USD | 11.13% |
| 2002 Q4 | 15.89 Million USD | -9.65% |
| 2002 FY | 66.85 Million USD | 16.41% |
| 2002 Q1 | 16.38 Million USD | -15.95% |
| 2002 Q2 | 16.97 Million USD | 3.59% |
| 2002 Q3 | 17.59 Million USD | 3.63% |
| 2001 FY | 57.42 Million USD | 50.45% |
| 2001 Q2 | 13.07 Million USD | -9.96% |
| 2001 Q3 | 13.16 Million USD | 0.7% |
| 2001 Q4 | 19.49 Million USD | 48.09% |
| 2001 Q1 | 14.52 Million USD | 19.03% |
| 2000 Q1 | 7.03 Million USD | 38.0% |
| 2000 Q3 | 9.9 Million USD | 9.77% |
| 2000 Q4 | 12.19 Million USD | 23.12% |
| 2000 FY | 38.17 Million USD | 84.4% |
| 2000 Q2 | 9.02 Million USD | 28.25% |
| 1999 Q1 | 2.6 Million USD | -7.14% |
| 1999 Q3 | 6 Million USD | 30.43% |
| 1999 Q4 | 5.1 Million USD | -15.0% |
| 1999 FY | 20.7 Million USD | 81.58% |
| 1999 Q2 | 4.6 Million USD | 76.92% |
| 1998 FY | 11.4 Million USD | 20.0% |
| 1998 Q3 | 2.7 Million USD | 12.5% |
| 1998 Q4 | 2.8 Million USD | 3.7% |
| 1998 Q1 | 3.5 Million USD | 59.09% |
| 1998 Q2 | 2.4 Million USD | -31.43% |
| 1997 Q2 | 2.5 Million USD | 19.05% |
| 1997 FY | 9.5 Million USD | 13.1% |
| 1997 Q4 | 2.2 Million USD | -18.52% |
| 1997 Q3 | 2.7 Million USD | 8.0% |
| 1997 Q1 | 2.1 Million USD | 5.0% |
| 1996 FY | 8.4 Million USD | 25.37% |
| 1996 Q1 | 2 Million USD | 25.0% |
| 1996 Q2 | 2.7 Million USD | 35.0% |
| 1996 Q3 | 1.9 Million USD | -29.63% |
| 1996 Q4 | 2 Million USD | 5.26% |
| 1995 Q4 | 1.6 Million USD | -23.81% |
| 1995 FY | 6.7 Million USD | 0.0% |
| 1995 Q3 | 2.1 Million USD | -8.7% |
| 1995 Q2 | 2.3 Million USD | 0.0% |
| 1995 Q1 | 2.3 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -34738.941% |
| IceCure Medical Ltd | 1.3 Million USD | -68237.923% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -194502.392% |
| Acutus Medical, Inc. | -3.13 Million USD | 28419.828% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Bioventus Inc. | 328.19 Million USD | -170.692% |
| BrainsWay Ltd. | 23.09 Million USD | -3747.356% |
| Cerus Corporation | 86.4 Million USD | -928.233% |
| Venus Concept Inc. | 52.16 Million USD | -1602.979% |
| Envoy Medical, Inc. | -473 Thousand USD | 187920.93% |
| CVRx, Inc. | 33.03 Million USD | -2588.922% |
| electroCore, Inc. | 13.22 Million USD | -6617.02% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -1456281.967% |
| Inogen, Inc. | 126.69 Million USD | -601.184% |
| OrthoPediatrics Corp. | 111.25 Million USD | -698.534% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 14784.182% |
| Spectral AI, Inc. | 7.88 Million USD | -11174.023% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1876880.886% |
| MaxCyte, Inc. | 36.54 Million USD | -2330.89% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 13576.836% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1044330.99% |
| Orthofix Medical Inc. | 486.27 Million USD | -82.694% |
| PAVmed Inc | -3.96 Million USD | 22488.936% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 16296.773% |
| RxSight, Inc. | 53.76 Million USD | -1552.363% |
| Sight Sciences, Inc. | 69.17 Million USD | -1184.269% |
| SI-BONE, Inc. | 109.42 Million USD | -711.911% |
| TELA Bio, Inc. | 40.11 Million USD | -2114.781% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -484.711% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -10641.059% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -5485.27% |
| LivaNova PLC | 771.25 Million USD | -15.189% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -120030.056% |
| Talis Biomedical Corporation | 371 Thousand USD | -239359.03% |
| 908 Devices Inc. | 25.32 Million USD | -3408.384% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -186.391% |
| Nemaura Medical Inc. | -1.47 Million USD | 60273.247% |
| NeuroPace, Inc. | 48.12 Million USD | -1746.127% |
| LENSAR, Inc. | 21.1 Million USD | -4108.997% |
| Apyx Medical Corporation | 14.12 Million USD | -6190.844% |
| Cutera, Inc. | 41.49 Million USD | -2041.016% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -4712.269% |
| BioSig Technologies, Inc. | 18 Thousand USD | -4935416.667% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -761.781% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -6425.584% |
| Axonics, Inc. | 274.55 Million USD | -223.577% |
| Outset Medical, Inc. | 29 Million USD | -2963.424% |
| IRIDEX Corporation | 21.8 Million USD | -3973.889% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -1150.395% |
| IRadimed Corporation | 50.15 Million USD | -1671.18% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -309444.599% |
| INVO Bioscience, Inc. | 1.08 Million USD | -81693.75% |
| Telesis Bio, Inc. | 16.95 Million USD | -5141.257% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -687.701% |
| Varex Imaging Corporation | 256.9 Million USD | -245.813% |
| Quipt Home Medical Corp. | 163.84 Million USD | -442.216% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 218916.01% |
| Pulmonx Corporation | 50.75 Million USD | -1650.459% |
| Dynatronics Corporation | 7.63 Million USD | -11535.829% |
| Modular Medical, Inc. | -768 Thousand USD | 115776.172% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -15912.851% |
| Semler Scientific, Inc. | 61.2 Million USD | -1351.623% |
| InMode Ltd. | 411.34 Million USD | -115.975% |
| Bruker Corporation | 1.51 Billion USD | 41.43% |
| Cytosorbents Corporation | 22.39 Million USD | -3867.453% |
| DexCom, Inc. | 2.28 Billion USD | 61.187% |
| Align Technology, Inc. | 2.71 Billion USD | 67.323% |
| Viveve Medical, Inc. | 620 Thousand USD | -143189.194% |
| ZimVie Inc. | 290.38 Million USD | -205.938% |
| Movano Inc. | -158 Thousand USD | 562374.051% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -711.866% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1044330.99% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | -141.615% |
| Profound Medical Corp. | 4.51 Million USD | -19580.746% |
| Insulet Corporation | 1.15 Billion USD | 23.408% |
| enVVeno Medical Corporation | -546 Thousand USD | 162809.341% |
| Surmodics, Inc. | 93.05 Million USD | -854.727% |
| iCAD, Inc. | 14.53 Million USD | -6011.674% |
| Nuwellis, Inc. | 4.98 Million USD | -17728.477% |
| Biotricity, Inc. | 8.35 Million USD | -10531.44% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -167.745% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 247523.947% |
| InspireMD, Inc. | 1.8 Million USD | -49063.973% |
| PAVmed Inc. | -3.96 Million USD | 22488.936% |
| BIOLASE, Inc. | 16.72 Million USD | -5212.084% |
| Beyond Air, Inc. | -1.3 Million USD | 68071.92% |
| FONAR Corporation | 45.14 Million USD | -1868.082% |
| AxoGen, Inc. | 127.87 Million USD | -594.741% |
| Vivani Medical, Inc. | -357 Thousand USD | 248949.58% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -355.276% |
| Inari Medical, Inc. | 434.56 Million USD | -104.433% |
| UFP Technologies, Inc. | 112.22 Million USD | -691.618% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -7096257.537% |
| Tenon Medical, Inc. | 1.24 Million USD | -71486.865% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1096881.481% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -33716.631% |
| AdaptHealth Corp. | 479.56 Million USD | -85.25% |
| Sintx Technologies, Inc. | 1.84 Million USD | -48103.635% |
| NanoVibronix, Inc. | 1.53 Million USD | -57700.455% |
| Quanterix Corporation | 70.64 Million USD | -1157.528% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 218916.01% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -6218.585% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -1583.2% |
| TransMedics Group, Inc. | 154.09 Million USD | -476.53% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -19850.438% |
| NeuroMetrix, Inc. | 3.94 Million USD | -22405.702% |
| Hyperfine, Inc. | 4.75 Million USD | -18575.489% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -730.452% |
| Biomerica, Inc. | 611 Thousand USD | -145299.836% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -2031.084% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 113857.259% |
| Silk Road Medical, Inc | 127.08 Million USD | -599.049% |